--- title: Nanotalks, Curapath blog | LNP description: LNP | Explore Curapath's blog dive into PNP and LNP formulations, GMP manufacturing, and solutions for non-viral gene therapy, all this in Nanotalks by Curapath image: https://blog.curapath.com/hubfs/Captura%20de%20pantalla%202025-03-10%20102446.png --- [Skip to content](https://blog.curapath.com/tag/lnp#main-content) [![White](https://blog.curapath.com/hs-fs/hubfs/White.png?width=553&height=208&name=White.png "White")](https://curapath.com/) - [Resources](https://resources.curapath.com/en/curapath-resource-library) - [End to end services](https://curapath.com/end-to-end-services/) - [Expertise](https://curapath.com/expertise/) - [Products](https://curapath.com/products) - [Blog](https://blog.curapath.com) - [Contact Us](https://curapath.com/contact-us/)  ![](https://blog.curapath.com/hs-fs/hubfs/logo%20Nanotalks%20blog%20Curapath%20banco-png.png?width=6000&height=3375&name=logo%20Nanotalks%20blog%20Curapath%20banco-png.png) NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine Hot topics # LNP Keep exploring Curapath Blog , there is more NanoTalks yet to explore ## Recent Articles - Filter by: - [All](https://blog.curapath.com/all) - [Polymers](https://blog.curapath.com/tag/polymers) - [LNP](https://blog.curapath.com/tag/lnp) - [Regulatory](https://blog.curapath.com/tag/regulatory) - [Analytics](https://blog.curapath.com/tag/analytics) - [PNP](https://blog.curapath.com/tag/pnp) [![](https://blog.curapath.com/hubfs/fotos%20blog%20paaa.png)](https://blog.curapath.com/polyaminoacids-in-drug-delivery) [Polymers](https://blog.curapath.com/tag/polymers), [LNP](https://blog.curapath.com/tag/lnp), [PNP](https://blog.curapath.com/tag/pnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - October 14, 2026 ### [Polyaminoacids in drug delivery](https://blog.curapath.com/polyaminoacids-in-drug-delivery) From biodegradable carriers to stimuli-responsive and multifunctional nanomedicines, poly(amino acids) are opening new... [Read more](https://blog.curapath.com/polyaminoacids-in-drug-delivery) [![](https://blog.curapath.com/hubfs/pnp%20vs%20LNP.png)](https://blog.curapath.com/lnps-or-pnps-that-is-the-question) [Polymers](https://blog.curapath.com/tag/polymers), [LNP](https://blog.curapath.com/tag/lnp), [PNP](https://blog.curapath.com/tag/pnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - September 8, 2026 ### [LNPs or PNPs that is the question](https://blog.curapath.com/lnps-or-pnps-that-is-the-question) Lipid nanoparticles (LNPs) and polymeric nanoparticles (PNPs) are two leading non-viral drug delivery platforms. While... [Read more](https://blog.curapath.com/lnps-or-pnps-that-is-the-question) [![Targeted LNPs](https://blog.curapath.com/hubfs/fotos%20blog%20(5).png)](https://blog.curapath.com/active-targeting-in-lnps-why-surface-functionalization-matters) [LNP](https://blog.curapath.com/tag/lnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - April 28, 2026 ### [Active Targeting in LNPs: Why Surface Functionalization Matters](https://blog.curapath.com/active-targeting-in-lnps-why-surface-functionalization-matters) Active targeting has emerged as one of the most promising strategies to unlock extrahepatic delivery of nanoparticles,... [Read more](https://blog.curapath.com/active-targeting-in-lnps-why-surface-functionalization-matters) [![LNP manufacturing](https://blog.curapath.com/hubfs/fotos%20blog%20(3).png)](https://blog.curapath.com/lnp-manufacturing-process) [LNP](https://blog.curapath.com/tag/lnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - April 2, 2026 ### [LNP Manufacturing Process: From Formulation to GMP Production](https://blog.curapath.com/lnp-manufacturing-process) The outcome of this step directly defines critical quality attributes, including: Particle size Polydispersity index... [Read more](https://blog.curapath.com/lnp-manufacturing-process) [![](https://blog.curapath.com/hubfs/fotos%20blog%20(2).png)](https://blog.curapath.com/advanced-analytical-characterization-of-polymeric-excipients) [Polymers](https://blog.curapath.com/tag/polymers), [LNP](https://blog.curapath.com/tag/lnp), [Analytics](https://blog.curapath.com/tag/analytics) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - February 26, 2026 ### [Advanced Analytical Characterization of Polymeric Excipients](https://blog.curapath.com/advanced-analytical-characterization-of-polymeric-excipients) Polymeric excipients play a critical role in modern therapeutic systems being a fundamental partin advanced and highly... [Read more](https://blog.curapath.com/advanced-analytical-characterization-of-polymeric-excipients) [![](https://blog.curapath.com/hubfs/fotos%20blog.jpg)](https://blog.curapath.com/beyond-lipids-and-polymers-understanding-hybrid-nanoparticles) [Polymers](https://blog.curapath.com/tag/polymers), [LNP](https://blog.curapath.com/tag/lnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - November 13, 2025 ### [Beyond Lipids and Polymers: Understanding Hybrid Nanoparticles](https://blog.curapath.com/beyond-lipids-and-polymers-understanding-hybrid-nanoparticles) Lipid–polymer hybrid nanoparticles (LPHNs) are emerging as one of the most promising platforms in nanomedicine.... [Read more](https://blog.curapath.com/beyond-lipids-and-polymers-understanding-hybrid-nanoparticles) [![Peg Alternatives page photo](https://blog.curapath.com/hubfs/Dise%C3%B1o%20sin%20t%C3%ADtulo%20(6).png)](https://blog.curapath.com/peg-alternatives) [LNP](https://blog.curapath.com/tag/lnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - July 30, 2025 ### [PEG Alternatives: Polymers Reshaping Lipid Nanoparticle Drug Delivery](https://blog.curapath.com/peg-alternatives) Replacing PEG in lipid nanoparticles (LNPs) marks a critical evolution in the development of safer and more effective... [Read more](https://blog.curapath.com/peg-alternatives) [![](https://blog.curapath.com/hubfs/Blog.jpg)](https://blog.curapath.com/reimagining-car-t-therapy-in-vivo-engineering-with-lipid-nanoparticles) [LNP](https://blog.curapath.com/tag/lnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - June 9, 2025 ### [In Vivo CAR-T Therapy with Lipid Nanoparticles: A Non-Viral Approach](https://blog.curapath.com/reimagining-car-t-therapy-in-vivo-engineering-with-lipid-nanoparticles) [Read more](https://blog.curapath.com/reimagining-car-t-therapy-in-vivo-engineering-with-lipid-nanoparticles) [![](https://blog.curapath.com/hubfs/Blog%20%20NANOTALK%20est%C3%A9tica%20banner%20(1).jpg)](https://blog.curapath.com/mrna-vaccines-therapies) [LNP](https://blog.curapath.com/tag/lnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - May 19, 2025 ### [mRNA Technologies: Vaccines vs Therapeutics](https://blog.curapath.com/mrna-vaccines-therapies) Messenger RNA (mRNA) technology surged into the global spotlight during the COVID-19 pandemic, showcasing its power to... [Read more](https://blog.curapath.com/mrna-vaccines-therapies) [![](https://blog.curapath.com/hubfs/freepik__the-style-is-candid-image-photography-with-natural__94715.jpeg)](https://blog.curapath.com/active-passive-tageting-nanoparticles) [LNP](https://blog.curapath.com/tag/lnp) - [Miguel Ángel Esteve](https://blog.curapath.com/author/miguel-ángel-esteve) - March 20, 2025 ### [The Impact of Passive and Active Targeting in Nanoparticles](https://blog.curapath.com/active-passive-tageting-nanoparticles) Nanoparticle-based drug delivery has revolutionized how therapeutics can be transported and released within the human... [Read more](https://blog.curapath.com/active-passive-tageting-nanoparticles) PREVIOUS [1](https://blog.curapath.com) [2](https://blog.curapath.com/tag/lnp/page/2) [NEXT](https://blog.curapath.com/tag/lnp/page/2) Keep updated ### Sign Up for NanoTalks Subscribe to NanoTalks, the magazine of Curapath. Stay up to date on the latest developments, trends and news in the world of non-viral vectors, plus discover the latest advances in nanobiotechnology.  [![Inverted](https://blog.curapath.com/hs-fs/hubfs/Inverted.png?width=300&height=113&name=Inverted.png "Inverted")](https://curapath.com/) Toggle 1. [About](https://curapath.com/about-us/) 2. [End-To-End Services](https://curapath.com/end-to-end-services/) 3. [Expertise](https://curapath.com/expertise/) 4. [News & Resources](https://curapath.com/news-events/) 5. [Contact Us](https://curapath.com/contact-us/) --- [Follow us on LinkedIn](https://www.linkedin.com/company/polypeptide-therapeutic-solutions/mycompany/) [Follow us on Twitter](https://curapath.wpengine.com/)